Author/Creator: Scharfstein, Daniel - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Scharfstein, Daniel

1. A Bayesian nonparametric approach for evaluating the causal effect of treatment in randomized trials with semi-competing risks. (4th April 2020)

Authors:: Xu, Yanxun; Scharfstein, Daniel; Müller, Peter; Daniels, Michael
Journal:: Biostatistics
Issue:: Volume 23:Number 1(2022)
Page Start:: 34
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Exzidieren oder nicht: Auswirkung von MelaFind auf Biopsie‐Entscheidungen atypischer Läsionen bei deutschen Dermatologen. (July 2014)

Authors:: Hauschild, Axel; Chen, Suephy C.; Weichenthal, Michael; Blum, Andreas; King, Hadley C.; Goldsmith, Jeff; Scharfstein, Daniel; Gutkowicz‐Krusin, Dina
Journal:: Journal der Deutschen Dermatologischen Gesellschaft
Issue:: Volume 12:Number 7(2014)
Page Start:: 606
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Global sensitivity analysis for repeated measures studies with informative drop‐out: A semi‐parametric approach. Issue 1 (23rd May 2017)

Authors:: Scharfstein, Daniel; McDermott, Aidan; Díaz, Iván; Carone, Marco; Lunardon, Nicola; Turkoz, Ibrahim
Journal:: Biometrics
Issue:: Volume 74:Issue 1(2018)
Page Start:: 207
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes. Issue 4 (11th October 2020)

Authors:: Benkeser, David; Díaz, Iván; Luedtke, Alex; Segal, Jodi; Scharfstein, Daniel; Rosenblum, Michael
Journal:: Biometrics
Issue:: Volume 77:Issue 4(2021)
Page Start:: 1467
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Rejoinder: Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes. Issue 4 (29th May 2021)

Authors:: Benkeser, David; Díaz, Iván; Luedtke, Alex; Segal, Jodi; Scharfstein, Daniel; Rosenblum, Michael
Journal:: Biometrics
Issue:: Volume 77:Issue 4(2021)
Page Start:: 1492
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. (18th June 2014)

Authors:: Hauschild, Axel; Chen, Suephy C.; Weichenthal, Michael; Blum, Andreas; King, Hadley C.; Goldsmith, Jeff; Scharfstein, Daniel; Gutkowicz‐Krusin, Dina
Journal:: Journal der Deutschen Dermatologischen Gesellschaft
Issue:: Volume 12:Number 7(2014)
Page Start:: 606
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗